ScreenerHero

PLRZ Polyrizon Ltd.

NAS · US · Healthcare · Biotechnology · polyrizon-biotech.com
9.150USD-5.37%Mkt Cap: 22.22M $P/E: —

Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and …

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap22.22M USD
Enterprise Value4.48M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-3.33M USD
Revenue/Share—
Last Price9.150 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees2
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-0.57
EV/Revenue—
P/S—
P/B0.84
EPS (TTM)-4.97
EPS (Forward)—
52W Range
2.88041% of range18.20
52W High18.20 USD
52W Low2.880 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-15.89%
ROA-15.56%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.53M USD
CapEx (TTM)7.00K USD
FCF Margin—
FCF Yield-9.39%
Net Debt-16.07M USD
Net Debt/EBITDA2.06
Balance Sheet
Debt/Equity—
Current Ratio36.37
Quick Ratio35.88
Book Value/Sh11.48 USD
Cash/Share7.56 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:6
Split DateNov 28, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.2.43M
Float1.87M
Insiders0.73%
Institutions9.35%
Short Interest
Short Ratio0.6d
Short % Float2.37%
Short % Out.2.34%
Shares Short55.52K
Short (prev mo.)94.22K
Technical
SMA 5011.20 (-18.3%)
SMA 20012.77 (-28.4%)
Beta—
S&P 52W Chg15.78%
Avg Vol (30d)57.36K
Avg Vol (10d)16.32K
Technical Indicators
RSI (14)36.7
MACD-0.5485
MACD Signal-0.4088
MACD Hist.-0.1397
BB Upper11.89 USD
BB Middle10.56 USD
BB Lower9.234 USD
BB Width25.19%
ATR (14)0.9188 USD
Vol Ratio (20d)0.15x